Last 12 months
Inside the activity.
1 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 9 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 15, 2019 Filed Jan 17, 2019 21:05 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 1,284 | $57.00 | $73,188.00 |
DisclosureSEC source: 0001179110-19-000826 · edgar.xml · nonDerivative · entry 2 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 14, 2018. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 21:05 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 1,284 | $35.45 | $45,517.80 |
DisclosureSEC source: 0001179110-19-000826 · edgar.xml · nonDerivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,447 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · derivative · entry 9 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,615 Underlying: Common Stock · 1,447 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 913 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · derivative · entry 8 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,790 Underlying: Common Stock · 913 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 456 | $0.00 Strike: $9.60 | $0.00 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,278 Underlying: Common Stock · 456 shares Expires 2025-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 29, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,734 | $0.00 Strike: $8.71 | $0.00 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,468 Underlying: Common Stock · 2,734 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 25, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
SaleCommon Stock | 5,500 | $53.80 | $295,900.00 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · nonDerivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 1,447 | $22.30 | $32,268.10 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 913 | $12.21 | $11,147.73 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 456 | $9.60 | $4,377.60 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:06 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 2,734 | $8.71 | $23,813.14 |
DisclosureSEC source: 0001179110-19-000651 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:05 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 645 | $0.00 Strike: $35.45 | $0.00 |
DisclosureSEC source: 0001179110-19-000650 · edgar.xml · derivative · entry 3 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,822 Underlying: Common Stock · 645 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:05 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 645 | $55.00 | $35,475.00 |
DisclosureSEC source: 0001179110-19-000650 · edgar.xml · nonDerivative · entry 2 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 14, 2018. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:05 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 645 | $35.45 | $22,865.25 |
DisclosureSEC source: 0001179110-19-000650 · edgar.xml · nonDerivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:00 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 33,276 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · derivative · entry 11 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,243 Underlying: Common Stock · 33,276 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:00 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,988 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · derivative · entry 10 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,618 Underlying: Common Stock · 9,988 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested as to 25% of the shares on January 1, 2016. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:00 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 22,401 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · derivative · entry 9 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,205 Underlying: Common Stock · 22,401 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to 25% of the shares on January 1, 2015 The remainder of the shares vested or will vest in 30 equal monthly installments thereafter. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:00 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 31,870 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · derivative · entry 8 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,156 Underlying: Common Stock · 31,870 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:00 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 33,276 | $6.01 | $199,988.76 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · nonDerivative · entry 6 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:00 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 9,988 | $1.67 | $16,679.96 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · nonDerivative · entry 5 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 570,443 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:00 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 22,401 | $1.67 | $37,409.67 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · nonDerivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:00 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 31,870 | $1.07 | $34,100.90 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 538,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 19, 2018 Filed Dec 21, 2018 21:00 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · derivative · entry 7 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,026 Underlying: Common Stock · 30,000 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. Read SEC document |
| December 19, 2018 Filed Dec 21, 2018 21:00 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
SaleCommon Stock | 30,000 | $49.55 | $1,486,500.00 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506,184 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. F2 · price: Represents the weighted average price of transactions ranging from $49.26 to $50.24. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 19, 2018 Filed Dec 21, 2018 21:00 UTC |
Gorevic Jason NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 30,000 | $1.07 | $32,100.00 |
DisclosureSEC source: 0001179110-18-014224 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 16:38 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,734 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-014139 · edgar.xml · derivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,734 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on December 18, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 16:38 UTC |
Turitz AndrewSVP - Business Development
|
SaleCommon Stock | 2,734 | $50.01 | $136,727.34 |
DisclosureSEC source: 0001179110-18-014139 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,176 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018. Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 16:38 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionCommon Stock | 2,734 | $6.01 | $16,431.34 |
DisclosureSEC source: 0001179110-18-014139 · edgar.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 21:38 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 640 | $0.00 Strike: $35.45 | $0.00 |
DisclosureSEC source: 0001179110-18-014140 · edgar.xml · derivative · entry 3 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,467 Underlying: Common Stock · 640 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 21:38 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 640 | $50.00 | $32,000.00 |
DisclosureSEC source: 0001179110-18-014140 · edgar.xml · nonDerivative · entry 2 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 14, 2018. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 21:38 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 640 | $35.45 | $22,688.00 |
DisclosureSEC source: 0001179110-18-014140 · edgar.xml · nonDerivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC |
HIRSCHHORN MARKExecutive VP, COO and CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 293 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · derivative · entry 10 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,352 Underlying: Common Stock · 293 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC |
HIRSCHHORN MARKExecutive VP, COO and CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,081 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · derivative · entry 9 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,194 Underlying: Common Stock · 3,081 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC |
HIRSCHHORN MARKExecutive VP, COO and CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,284 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · derivative · entry 8 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,692 Underlying: Common Stock · 2,284 shares Expires 2024-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on December 22, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC |
HIRSCHHORN MARKExecutive VP, COO and CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 684 | $0.00 Strike: $6.01 | $0.00 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · derivative · entry 7 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,151 Underlying: Common Stock · 684 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on September 10, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC |
HIRSCHHORN MARKExecutive VP, COO and CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,001 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · derivative · entry 6 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,008 Underlying: Common Stock · 1,001 shares Expires 2023-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vests as to 25% of the shares on December 11, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC |
HIRSCHHORN MARKExecutive VP, COO and CFO
|
Exercise / conversionCommon Stock | 293 | $22.30 | $6,533.90 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · nonDerivative · entry 5 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC |
HIRSCHHORN MARKExecutive VP, COO and CFO
|
Exercise / conversionCommon Stock | 3,081 | $12.21 | $37,619.01 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · nonDerivative · entry 4 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC |
HIRSCHHORN MARKExecutive VP, COO and CFO
|
Exercise / conversionCommon Stock | 2,284 | $6.01 | $13,726.84 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · nonDerivative · entry 3 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,626 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC |
HIRSCHHORN MARKExecutive VP, COO and CFO
|
Exercise / conversionCommon Stock | 684 | $6.01 | $4,110.84 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · nonDerivative · entry 2 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:02 UTC |
HIRSCHHORN MARKExecutive VP, COO and CFO
|
Exercise / conversionCommon Stock | 1,001 | $1.67 | $1,671.67 |
DisclosureSEC source: 0001179110-18-013920 · edgar.xml · nonDerivative · entry 1 HIRSCHHORN MARK · CIK 0001081343 · Executive VP, COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:01 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,446 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-18-013737 · edgar.xml · derivative · entry 9 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,062 Underlying: Common Stock · 1,446 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:01 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 914 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-18-013737 · edgar.xml · derivative · entry 8 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,703 Underlying: Common Stock · 914 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:01 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 456 | $0.00 Strike: $9.60 | $0.00 |
DisclosureSEC source: 0001179110-18-013737 · edgar.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,734 Underlying: Common Stock · 456 shares Expires 2025-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on May 29, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:01 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,734 | $0.00 Strike: $8.71 | $0.00 |
DisclosureSEC source: 0001179110-18-013737 · edgar.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,202 Underlying: Common Stock · 2,734 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on February 25, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:01 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
SaleCommon Stock | 5,550 | $54.19 | $300,754.50 |
DisclosureSEC source: 0001179110-18-013737 · edgar.xml · nonDerivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018. F2 · price: Represents the weighted average price of transactions ranging from $54.00 to $54.64. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:01 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 1,446 | $22.30 | $32,245.80 |
DisclosureSEC source: 0001179110-18-013737 · edgar.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:01 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 914 | $12.21 | $11,159.94 |
DisclosureSEC source: 0001179110-18-013737 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:01 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 456 | $9.60 | $4,377.60 |
DisclosureSEC source: 0001179110-18-013737 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:01 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 2,734 | $8.71 | $23,813.14 |
DisclosureSEC source: 0001179110-18-013737 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.